Adjuvant chemotherapy in stage II breast cancer: a brief overview of the NSABP clinical trials.
Wolmark
N
N
Fisher
B
B
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009367:Neoplasm Staging; D011897:Random Allocation
D004317:Doxorubicin; D008558:Melphalan; D005472:Fluorouracil; D008727:Methotrexate